Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 38,461 shares at $3.68 ($142K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
Seasonal sale ($142k) by Chief Financial Officer — this insider has traded RLAY in July in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.74 | 1,701 | $6K | 4.5% |
| 2 | $3.68 | 18,380 | $68K | 47.8% |
| 3 | $3.68 | 18,380 | $68K | 47.8% |
| Total | $3.68 avg | 38,461 | $142K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |